SHELTON, CT / ACCESS Newswire / July 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Science works at a much slower pace than social media, opening a large window for early findings to be taken at face value ...
The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three ...
Multiple new clinical trials are underway to evaluate if various treatments will prove effective against the Bundibugyo Ebola ...